Novo Nordisk's pricing approaches inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of value gouging, pointing out the stark distinction concerning U.S. prices and those in Europe and copyright.In October 2024, Novo Nordisk posted a examine on scientific journal Mother nature a couple of nov